Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02675205
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Registry
-
NCT02675205 -
2014-005720-10
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT02675205. Randomized; no masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2020-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm
- Acronym
- TIC-TAC
- Condition
- Cerebral Aneurysm
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- aspirin
- Lead sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
Record details
- Record id
cardio:ct-nct02675205- Content hash
e476b73783e7fea0399a9ce1c3d1eb9f62e222b3b51d0e42f6d7ffa1d3812b1c